FRIDAY, Oct. 13 (HealthDay News) -- Measuring levels of cells that originate in bone marrow could help doctors predict outcomes for liver cancer patients, researchers say.
Patients with inoperable heptocellular carcinoma (HCC) had higher levels of "endothelial progenitor cells" (EPCs) -- precursors to the endothelial cells that line blood vessels -- compared to patients with liver tumors that could be treated surgically.
Continue reading Test May Predict Liver Cancer Prognosis.
